Maspin in thyroid cancer: its relationship with p53 and clinical outcome.

Oncology reports

Volumn 10, Issue 6, 2003, Pages 1783-1787

  Boltze, Carsten ^a   Schneider Stock, Regine ^a   Meyer, Frank ^a   Peters, Brigitte ^a   Quednow, Claudia ^a   Hoang Vu, Cuong ^a   Roessner, Albert ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MASPIN; PROTEIN; PROTEIN P53; SERINE PROTEINASE INHIBITOR;

ADULT; AGED; ARTICLE; BINDING SITE; BIOSYNTHESIS; CARCINOMA; CELL DIFFERENTIATION; CELL SURVIVAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MUTATION; PAPILLARY CARCINOMA; PHYSIOLOGY; PROGNOSIS; RECURRENT DISEASE; THYROID TUMOR; TIME; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BINDING SITES; CARCINOMA; CARCINOMA, PAPILLARY; CELL DIFFERENTIATION; CELL SURVIVAL; DISEASE-FREE SURVIVAL; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; PROGNOSIS; PROTEINS; RECURRENCE; SERPINS; THYROID NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2642576111     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.10.6.1783     Document Type: Article

References (0)